Luminary Therapeutics, Inc.

Biotechnology company · Minneapolis, Minnesota, United States

Luminary Therapeutics, Inc. is a biotechnology company headquartered in Minneapolis, Minnesota, United States. Its earliest recorded incorporation is in 2019. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $3.4 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $1.4 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Luminary Therapeutics at a glance

Typebiotechnology company
HeadquartersMinneapolis, Minnesota, United States
Earliest incorporation on record2019
Employees (per SBIR records)7
SEC CIK1793860

What does Luminary Therapeutics do?

US government research funding

6 SBIR/STTR small-business research awards from US health agencies, $3.4 million in total (2020 to 2025). NIH funding came from the National Cancer Institute, National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

8 Form D notices; the most recent reported $1.4 million sold (2025).

Frequently asked questions about Luminary Therapeutics

Where is Luminary Therapeutics headquartered?

Luminary Therapeutics, Inc. is headquartered in Minneapolis, Minnesota, United States.

What does Luminary Therapeutics do?

Luminary Therapeutics, Inc. is a biotechnology company.

When was Luminary Therapeutics founded?

The earliest incorporation on record for Luminary Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.